Prevalence of Regulatory T-Cell Subtypes in Preeclampsia

American Journal of Reproductive Immunology

Volumn 74, Issue 2, 2015, Pages 110-115

  Toldi, Gergely ^a   Vásárhelyi, Zsófia Eszter ^a   Rigó, János ^a   Orbán, Csaba ^b   Tamássy, Zita ^a   Bajnok, Anna ^b   Shima, Tomoko ^c   Saito, Shigeru ^c   Molvarec, Attila ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

CD279; Effector Treg; Exhausted Treg; Helios; Naive Treg; Preeclampsia

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HELIOS; UNCLASSIFIED DRUG; CD45 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR REGULATORY T CELL; EXHAUSTED REGULATORY T CELL; EXTRATHYMIC REGULATORY T CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; NAIVE REGULATORY T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREECLAMPSIA; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THIRD TRIMESTER PREGNANCY; THYMIC REGULATORY T CELL; IMMUNOLOGY; PREGNANCY;

ADULT; ANTIGENS, CD45; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; PRE-ECLAMPSIA; PREGNANCY; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES, REGULATORY;

EID: 84935447120     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12380     Document Type: Article

References (31)

1. Redman CW, Sacks GP, Sargent IL: Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
2. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y: The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28:192-209.
3. Saito S, Sakai M: Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161-173.
4. Saito S, Nakashima A, Shima T, Ito M: Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63:601-610.
5. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell 2008; 133:775-787.
6. Quinn KH, Parast MM: Decidual regulatory T cells in placental pathology and pregnancy complications. Am J Reprod Immunol 2013; 69:533-538.
7. Samstein R, Josefowicz S, Arvey A, Treuting P, Rudensky A: Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012; 150:29-38.
8. Aluvihare V, Kallikourdis M, Betz A: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271.
9. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, Shiozaki A, Rolinski J, Saito S: Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in preeclampsia. Clin Exp Immunol 2007; 149:139-145.
10. Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz B, Leszczynska-Gorzelak B, Oleszczuk J: Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 2007; 58:39-45.
11. Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ, Erwich JJ: Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy 2009; 28:300-311.
12. Steinborn A, Haensch GM, Mahnke K, Schmitt E, Toermer A, Meuer S, Sohn C: Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol 2008; 129:401-412.
13. Toldi G, Svec P, Vásárhelyi B, Mészáros G, Rigó J, Tulassay T, Treszl A: Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand 2008; 87:1229-1233.
14. Tilburgs T, Roelen DL, Van der Mast BJ, Van Scip JJ, Kleijburg C, de Groot-Swings GM, Kanhai HH, Claas FH, Scherjon SA: Differential distrubution of CD4+CD25bright and CD8+CD28- T-cells in decidua and maternal blood during human pregnancy. Placenta 2006; 27(Suppl. A):S47-S53.
15. Tilburgs T, Roelen D, van der Mast B, de Groot-Swings GM, Kleijburg C, Scherjon S, Claas F: Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 2008; 180:5737-5745.
16. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, Shevach EM: Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010; 184:3433-3441.
17. Zabransky DJ, Nirschl CJ, Durham NM, Park BV, Ceccato CM, Bruno TC, Tam AJ, Getnet D, Drake CG: Phenotypic and functional properties of Helios+ regulatory T cells. PLoS ONE 2012; 7:e34547.
18. Cai Q, Dierich A, Oulad-Abdelghani M, Chan S, Kastner P: Helios deficiency has minimal impact on T cell development and function. J Immunol 2009; 183:2303-2311.
19. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S: Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30:899-911.
20. Pan X, Yuan X, Zheng Y, Wang W, Shan J, Lin F, Jiang G, Yang YH, Wang D, Xu D, Shen L: Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. PLoS ONE 2012; 7:e34662.
21. Steinborn A, Schmitt E, Kisielewicz A, Rechenberg S, Seissler N, Mahnke K, Schaier M, Zeier M, Sohn C: Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol 2012; 167:84-98.
22. Saito S, Shima T, Inada K, Nakashima A: Which types of regulatory T cells play important roles in implantation and pregnancy maintenance? Am J Reprod Immunol 2013; 69:340-345.
23. Shen T, Zheng J, Liang H, Xu C, Chen X, Zhang T, Xu Q, Lu F: Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxp3+ Treg cells in chronic HCV infected-patients. Virol J 2011; 88:279.
24. Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, Labbadia G, Cerino A, Mondelli MU, Barnaba V: PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 2009; 119:551-564.
25. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439:682-687.
26. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354.
27. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ: Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 2003; 170:1257-1266.
28. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ: The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239-245.
29. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J: The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 2012; 93:75-81.
30. Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, Nanan R: Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol 2012; 181:2149-2160.
31. Inada K, Shima T, Ito M, Ushijima A, Saito S: Helios-positive functional regulatory T cells are decreased in decidua of miscarriage cases with normal fetal chromosomal content. J Reprod Immunol 2015; 107:10-19.